Treatment Interruption Decisions

Treatment Interruption Decisions is a clinical decision-making process in cardio-oncology that involves the temporary cessation or modification of cancer therapy due to cardiovascular toxicity, distinguished by its reliance on multidisciplinary risk stratification to balance oncologic efficacy and cardiovascular safety.

152

Publications

7.3K

Citations

1.1K

Authors

523

Institutions

Publications per year

2017–2026

44

Authors

1.1K

  1. FB
    François Bertucci

    Institut Paoli-Calmettes, France

    5 publications · 98 citations

    5

    h-index

  2. SC
    Sylvie Chabaud

    Centre Léon Bérard, France

    5 publications · 98 citations

    5

    h-index

  3. JB
    Jean‐Yves Blay

    Centre Léon Bérard, France

    5 publications · 98 citations

    5

    h-index

  4. AA
    Antoine Adenis

    Centre Oscar Lambret, France

    5 publications · 98 citations

    5

    h-index

  5. FD
    Florence Duffaud

    Hôpital de la Timone, France

    3 publications · 35 citations

    3

    h-index

1–5 of 1.1K

Venues

  1. PubMed

    Repository · 7 publications · 179 citations

    7

    h-index

  2. 5

    h-index

  3. AIDS

    5 publications · 328 citations

    5

    h-index

  4. 5

    h-index

  5. Journal of Clinical Oncology

    5 publications · 98 citations

    5

    h-index

1–5